 | Select the Course Number to get further detail on the course. Select the desired Schedule Type to find available classes for the course. The Schedule Type links will be available only when the schedule of classes is available for the selected term. |
| PHRM 84500 - Integrated Pharmacotherapy III |
|
Credit Hours: 6.00. This course will develop knowledge and skills regarding the physiology/ pathophysiology, medicinal chemistry, pharmacology, pharmacokinetics/pharmaceutics, and pharmacotherapy of specific cardiovascular diseases, neurology diseases, and psychiatric disorders. Typically offered Spring.
6.000 Credit hours Syllabus Available Levels: Undergraduate, Graduate, Professional Schedule Types: Lecture Offered By: College of Pharmacy Department: Dept of Pharm Practice May be offered at any of the following campuses: West Lafayette Learning Outcomes: 1. Explain structure-function relationships of drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine, headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence. 2. Explain the pharmacology of drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine, headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence. 3. Describe the pathophysiologic processes responsible for specific disease states and integrate this knowledge into the therapeutic decision making process. 4. Evaluate various therapeutic alternatives for a given disease state in light of specific patient factors and design a patient-specific pharmacotherapeutic regimen. This will include assessing the effectiveness of therapy on the basis of clinical and laboratory parameters. 5. Describe adverse effects associated with drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine/headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence. 6. Design evidence-based drug therapy treatment plans for patients with ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine/headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence. |
 |